Literature DB >> 23997451

HLA Antigens Shed from the Surface of Synthetic or Naturally Occurred Platelet-Derived Microparticles During Storage of Platelet Concentrate.

Fatemeh Yari1, Noushin Ahmadzadeh, Shima Azadpour, Shahram Vaeli.   

Abstract

The demand for standard platelet concentrates (PCs) has continued to increase in the recent years. Infusible platelet membranes (IPM) prepared from new or outdated human platelets have been developed as an alternative to standard PCs, with the additional advantage of long shelf life and increased viral safety. Reduction of HLA antigens on the IPM has been assigned as one of the probable advantages of this product. In re-examining this issue, we studied the existence of HLA class I on the surface of IPM microparticles. In comparison we also surveyed HLA expression on the surface of the naturally occurred platelet-derived microparticles (nPMPs) during 7 days storage. Intended for producing IPM, PCs obtained from Iranian blood transfusion organization were lysed; virally inactivated with wet heat in the presence of a heat stabilizer and then sonicated. IPMs were separated using centrifugation and liquid-stored in 4°C. The expression of HLA class I antigens was surveyed using flow cytometry technique. HLA molecules were present on the microparticles. Shedding of HLA antigens was demonstrated from the surface of the both liquid-stored IPM and nPMPs during storage. Storage of IPM in 4°C was accompanied with significant reduction of HLA molecules. It seemed that achievement of HLA-free IPM could be impossible unless chloroquine treated platelets were used to prepare these microvesicles.

Entities:  

Keywords:  HLA class I; IPM; Platelet-derived microparticles

Year:  2011        PMID: 23997451      PMCID: PMC3422389          DOI: 10.1007/s12288-011-0120-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  20 in total

1.  Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.

Authors:  C Gouttefangeas; M Diehl; W Keilholz; R F Hörnlein; S Stevanović; H G Rammensee
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

Review 2.  The reduction of HLA class I expression on platelets: a potential approach in the management of HLA-alloimmunized refractory patients.

Authors:  V M Novotný; I I Doxiadis; A Brand
Journal:  Transfus Med Rev       Date:  1999-04

Review 3.  Substitutes and alternatives to platelet transfusions in thrombocytopenic patients.

Authors:  M A Blajchman
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

4.  Production and characterization of liquid-stored and lyophilized reconstituted human infusible platelet membranes.

Authors:  N Ahmadzadeh; F Yari; N Amirizadeh; M R Khorramizadeh
Journal:  Int J Lab Hematol       Date:  2011-06-27       Impact factor: 2.877

5.  Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits.

Authors:  M McGill; D A Fugman; N Vittorio; C Darrow
Journal:  J Lab Clin Med       Date:  1987-02

6.  Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex.

Authors:  S S Graham; N J Gonchoroff; J L Miller
Journal:  Am J Clin Pathol       Date:  2001-01       Impact factor: 2.493

Review 7.  Platelet substitutes and novel platelet products.

Authors:  D H Lee; M A Blajchman
Journal:  Expert Opin Investig Drugs       Date:  2000-03       Impact factor: 6.206

Review 8.  Cellular microparticles: new players in the field of vascular disease?

Authors:  M Diamant; M E Tushuizen; A Sturk; R Nieuwland
Journal:  Eur J Clin Invest       Date:  2004-06       Impact factor: 4.686

9.  Transfer of membrane proteins from human platelets to liposomal fraction by interaction with liposomes containing an artificial boundary lipid.

Authors:  Y Okumura; M Ishitobi; M Sobel; K Akiyoshi; J Sunamoto
Journal:  Biochim Biophys Acta       Date:  1994-09-14

10.  Current concepts in platelet transfusion.

Authors:  Dipika Mohanty
Journal:  Asian J Transfus Sci       Date:  2009-01
View more
  2 in total

1.  Glycoproteins of GpIbα and GpIIbIIIa on the Synthetic or Naturally Occurred Platelet-Derived Microparticles.

Authors:  Shima Azadpour; Fatemeh Yari; Noushin Ahmadzadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-07-04       Impact factor: 0.900

2.  Interaction of Platelet-Derived Microparticles with a Human B-Lymphoblast Cell Line: A Clue for the Immunologic Function of the Microparticles.

Authors:  Fatemah Yari; Mahboubeh Motefaker; Mahin Nikougoftar; Zahra Khayati
Journal:  Transfus Med Hemother       Date:  2017-09-26       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.